#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1396	16S	1529	1529	100.0	16S.l15.c17.ctg.1	1812	141.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1368	1368	C	156	C	94	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1396	16S	1529	1529	100.0	16S.l15.c17.ctg.1	1812	141.6	0	HET	.	.	.	C1450T	.	1450	1450	C	1634	1634	C	148	C,T	75,13	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1396	16S	1529	1529	100.0	16S.l15.c17.ctg.1	1812	141.6	0	HET	.	.	.	C451T	.	451	451	C	635	635	C	154	C,T	56,43	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1396	16S	1529	1529	100.0	16S.l15.c17.ctg.1	1812	141.6	0	HET	.	.	.	C207T	.	207	207	C	391	391	C	119	C,T	45,33	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3764	130.5	0	.	n	.	0	T695C	SNP	695	695	T	1111	1111	C	147	C	88	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3764	130.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2387	2387	C	126	C	78	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3764	130.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2461	2461	A	128	A	85	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3764	130.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3013	3013	C	217	C	142	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	282	folP	855	855	100.0	folP.l15.c4.ctg.1	1574	32.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1005	1007	AGC	48;49;48	A;G;C	28;30;30	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	517	564	gyrA	2751	2289	99.83	gyrA.l6.c4.ctg.1	2641	31.7	1	SNP	p	S91F	1	.	.	271	273	TTC	623	625	TTC	40;40;40	T;T;C	27;26;26	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	517	564	gyrA	2751	2289	99.83	gyrA.l6.c4.ctg.1	2641	31.7	1	SNP	p	G95N	0	.	.	283	285	GGC	635	637	GGC	40;40;41	G;G;C	25;26;26	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	517	564	gyrA	2751	2289	99.83	gyrA.l6.c4.ctg.1	2641	31.7	1	SNP	p	D95G	1	.	.	283	285	GGC	635	637	GGC	40;40;41	G;G;C	25;26;26	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	517	564	gyrA	2751	574	99.83	gyrA.l6.c4.ctg.2	813	27.5	0	.	p	.	0	T752P	NONSYN	2254	2256	ACC	83	85	CCC	1;1;1	C,A;C;C	0,1;1;1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	152	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1134	24.8	1	SNP	p	G45D	0	.	.	133	135	GGC	413	415	GGC	51;51;51	G;G;C	29;31;31	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	178	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	706	41.8	0	.	n	.	0	A197.	DEL	197	197	A	371	371	A	70	A	40	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2816	46.5	1	SNP	p	D86N	0	.	.	256	258	GAC	497	499	GAC	53;53;54	G;A,C;C	31;27,1;32	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2816	46.5	1	SNP	p	S87R	1	.	.	259	261	CGT	500	502	CGT	54;54;54	C;G;T	34;29;31	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2816	46.5	1	SNP	p	R87W	0	.	.	259	261	CGT	500	502	CGT	54;54;54	C;G;T	34;29;31	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2816	46.5	1	SNP	p	R87I	0	.	.	259	261	CGT	500	502	CGT	54;54;54	C;G;T	34;29;31	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2816	46.5	1	SNP	p	S88P	0	.	.	262	264	TCC	503	505	TCC	54;54;54	T;C;C	31;32;34	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3120	37.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1678	1680	GGC	34;34;34	G;G;C	24;24;22	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	K533N	NONSYN	1597	1599	AAA	53	55	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	L534R	NONSYN	1600	1602	CTG	56	58	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	V535A	NONSYN	1603	1605	GTC	59	61	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	D537A	NONSYN	1609	1611	GAC	65	67	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	G538E	NONSYN	1612	1614	GGA	68	70	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	Y541S	NONSYN	1621	1623	TAC	77	79	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	V542S	NONSYN	1624	1626	GTC	80	82	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	A543P	NONSYN	1627	1629	GCC	83	85	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	Q555K	NONSYN	1663	1665	CAA	119	121	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	783	610	parE	1986	203	94.58	parE.l6.c17.ctg.2	491	0.0	0	.	p	.	0	L579R	NONSYN	1735	1737	CTG	191	193	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1287	1289	GCC	44;44;44	G;C;C	26;26;27	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1290	1292	ATG	44;44;44	A;T;G	27;26;27	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1302	1304	ACC	43;43;43	A;C;C	26;27;27	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1302	1304	ACC	43;43;43	A;C;C	26;27;27	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1803	1805	ACC	37;36;36	A;C;C	21;21;22	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1857	1859	GCG	39;39;39	G;C;G	22;21;22	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1857	1859	GCG	39;39;39	G;C;G	22;21;22	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1980	1982	GGT	39;39;35	G;G;T	25;24;21	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1989	1991	AGC	30;30;29	A;G;C	20;19;18	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	410	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2286	31.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2007	2009	CCG	21;21;21	C;C;G	11;11;10	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1014	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	2909	59.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1596	1598	CCG	41;41;41	C;C;G,A	23;25;23,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	218	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1892	20.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	298	298	C	29	C	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	264	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1569	32.0	0	.	p	.	0	G321S	NONSYN	961	963	GGC	1214	1216	AGC	24;24;24	A;G;C	17;19;17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	264	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1569	32.0	1	SNP	p	G120K	1	.	.	358	360	AAG	611	613	AAG	41;39;39	A,C;A;G	25,1;23;21	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	264	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1569	32.0	1	SNP	p	A121N	1	.	.	361	363	AAC	614	616	AAC	39;39;40	A;A;C	21;22;25	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	264	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1569	32.0	1	SNP	p	N121D	0	.	.	361	363	AAC	614	616	AAC	39;39;40	A;A;C	21;22;25	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	792	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4377	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	50	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	871	11.1	1	SNP	p	V57M	1	.	.	169	171	ATG	378	380	ATG	19;19;19	A;T;G	13;13;12	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
